EP Plenary session - Joint debate on Patents

Patents and plant breeders rights (debate)

Creation of unitary patent protection - Unitary patent protection - Jurisdictional system for patent disputes (debate)

Patenting of essential biological processes (debate)

Workshop - Policy Departements and Administration : Stem cell Research and patenting

ENVI

Enhanced cooperation in the area of the creation of unitary patent protection (debate)

JURI committee meeting. Exchange of views with Romanian Presidency. Presentation of study on Essential Patents and Internet of Things, commissioned by the European Parliament's Policy Department for Citizens' Rights and Constitutional Affairs at the request of JURI committee

Public Hearing - The Unitary patent : state of play in the context of Brexit

PAPADIMOULIS, Dimitrios (GUE/NGL, GR) - EP Vice-President

Plenary session week 51 2015 in Strasbourg - Patents and plant breeders rights - Oral question

Green meeting about patenting food and GMOs

JURI committee Hearing on Patent

Andreas MAVROYIANNIS, Raffaele BALDASSARRE, Martin SCHULZ - EP President

Lex Signing: European Unitary Patent Package

Plenary session week 50 -2012  in Strasbourg - European Patent

Press conference on the campaign against the patenting of biotechnical discoveries - No Patents on Life - with Nobel Prize for Literature winner Dario FO.

Martin SCHULZ - EP President, Evelyne GEBHARDT

Evelyne GEBHARDT and  M. THEN from No patents on Seeds Hand over a letter to Martin SCHULZ EP-President

Carl SCHLYTER, Raul ROMEVA I RUEDA, Elisabeth SCHROEDTER, Isabelle DURANT, Jose BOVE, Franziska BRANTNER, Martin HAUSLING, Jean-Paul BESSET, Nikos CHRYSOGELOS, Ulrike LUNACEK, Franziska KELLER

Greens / EFA group members stage a protest against patents in the agriculture sector

JURI Committee Meeting - Enhanced cooperation in the area of the creation of unitary patent protection with regard to the applicable translation arrangements

Illustration on the EU Patent at the Belgian Intellectual Property Office.

Press Conference on Biotechnical patents by: Eva LICHTENBERGER (Greens/EFA, AT) - Vittorio PRODI (S&D, IT) - Peter LIESE (EPP, DE)  - Miroslav MIKOLJIK (EPP, SL) - Carlo CASINI (EPP, IT)

Press conference in Strasbourg  : TRIPS and access to medicines - TRIPS : The EP was due to vote on whether to grant its assent to amending the TRIPS agreement to enable developing countries to make or import generic substitutes for patented medicines

Conference in Brussels on the European Patients' Rights day

No Software Patents demonstration at the EP in Strasbourg.

No Software Patents demonstration by the GreensEFA.

Intellectual property lies at the heart of innovation and competitiveness around the world as well as in the European Union. Intellectual property rights are protected mainly through patents, trademarks and copyright. They enable individuals and companies to earn recognition and/or financial benefit from what they invent or create. By striking the right balance between innovators and public interest, intellectual property aims to foster an environment in which creativity and innovation can flourish. But despite impressive patent activity, European businesses still encounter various challenges to register or protect patents. Restrictions: ©The material may not be edited and must be shown entirely.

EPRS - Key challenges for European patents

Parlamentet debatterade om huruvida patent på covid-19-vaccin bör slopas och antog ett mer inkluderande Erasmus+-program. Klimatet stod också på dagordningen: Parlamentsledamöterna godkände Fonden för en rättvis omställning för att hjälpa regioner under den gröna omställningen, och uppmanade EU att göra mer för att skydda miljöaktivister. Parlamentsledamöterna diskuterade även upptrappningen av konflikten mellan Israel och Palestina.

Höjdpunkter från plenarsammanträdet: Vaccinpatent för covid-19, Erasmus+ och miljön

During the plenary session of the European Parliament in Brussels (17-20 May 2021), MEPs debate proposal to the WTO to waive intellectual property rights for COVID-19 vaccines, a move backed by the US administration. Extracts from the debate: statements by Augusto SANTOS SILVA, Portuguese Minister of State for Foreign Affairs, Valdis DOMBROVSKIS, Executive Vice-President of the EC in charge of an Economy that works for People, Esther de LANGE (EPP, NL), Iratxe GARCÍA PÉREZ (S&D, ES), Dacian CIOLOŞ (Renew, RO), Tilly METZ (Greens/EFA, LU), Marc BOTENGA (The Left, BE), and Gilles LEBRETON (ID, FR).

Waiver of the Global Covid 19 vaccines patents: extracts from the debate

During the plenary session of the European Parliament in Brussels (17-20 May 2021), MEPs debate on the meeting the Global COVID-19 challenge: effects of waiver of the WTO TRIPS agreement on COVID-19 vaccines, treatment, equipment and manufacturing capacity in developing countries: Closing statements by Valdis DOMBROVSKIS, Executive Vice-President of the European Commission in charge of an Economy that works for People, and Commissioner for Trade and by Augusto SANTOS SILVA, Portuguese Minister of State for Foreign Affairs

Meeting the Global COVID-19 challenge: effects of waiver of the WTO TRIPS agreement on COVID-19 vaccines, treatment, equipment and manufacturing capacity in developing countries: Closing statements by Council and Comission

During the plenary session of the European Parliament in Brussels (17-20 May 2021), MEPs debate on the meeting the Global COVID-19 challenge: effects of waiver of the WTO TRIPS agreement on COVID-19 vaccines, treatment, equipment and manufacturing capacity in developing countries: MEPs debate part 1/3

Meeting the Global COVID-19 challenge: effects of waiver of the WTO TRIPS agreement on COVID-19 vaccines, treatment, equipment and manufacturing capacity in developing countries: MEPs debate part 1/3

During the plenary session of the European Parliament in Brussels (17-20 May 2021), MEPs debate on the meeting the Global COVID-19 challenge: effects of waiver of the WTO TRIPS agreement on COVID-19 vaccines, treatment, equipment and manufacturing capacity in developing countries: MEPs debate part 3/3

Meeting the Global COVID-19 challenge: effects of waiver of the WTO TRIPS agreement on COVID-19 vaccines, treatment, equipment and manufacturing capacity in developing countries: MEPs debate part 3/3

During the plenary session of the European Parliament in Brussels (17-20 May 2021), MEPs debate on the meeting the Global COVID-19 challenge: effects of waiver of the WTO TRIPS agreement on COVID-19 vaccines, treatment, equipment and manufacturing capacity in developing countries: MEPs debate part 2/3

Meeting the Global COVID-19 challenge: effects of waiver of the WTO TRIPS agreement on COVID-19 vaccines, treatment, equipment and manufacturing capacity in developing countries: MEPs debate part 2/3

During the plenary session of the European Parliament in Brussels (17-20 May 2021), MEPs debate on the meeting the Global COVID-19 challenge: effects of waiver of the WTO TRIPS agreement on COVID-19 vaccines, treatment, equipment and manufacturing capacity in developing countries: Opening statements by Augusto SANTOS SILVA, Portuguese Minister of State for Foreign Affairs and by Valdis DOMBROVSKIS, Executive Vice-President of the European Commission in charge of an Economy that works for People, and Commissioner for Trade.

Meeting the Global COVID-19 challenge: effects of waiver of the WTO TRIPS agreement on COVID-19 vaccines, treatment, equipment and manufacturing capacity in developing countries: Opening statements Council and Commission

Parlamentet upprepar sin uppmaning om gränsfri tillgång till växtförädlingsmaterial. Parlamentsledamöter vill säkerställa att lantbrukare i hela EU kan förnya för att hitta lösningar på klimatkrisen och nya växtsjukdomar. Rika multinationella företag ska inte tillåtas att ta patent på naturligt liv, genom att skapa monopol och driva upp livsmedelspriser.

Inga patent på växter och fröer som erhållits på naturlig väg

Slutsträckan för det gemensamma EU-patentet är en uppförsbacke, men det nya, enklare systemet utlovar sänkta patentkostnader med upp till 32 000 euro.

Att sänka kostnaderna för patent på upptäckter

Det gemensamma EU-patentet kommer att gynna företag i EU, anser Raffaele Baldassarre. Sophia in 't Veld nämner länder som bryter mot grundläggande rättigheter i Europa.

7 Dagar: Kamp för bättre rättigheter och EU-patent

Efter förhandlingar som pågått i 30 år kan detta vara sista akten för ett enda EU-patent. Vi talade med tyske EU-parlamentarikern Bernhard Rapkay och spanske EU-parlamentarikern Antonio Masip Hidalgo.

Samtalsämne: EU-patentet, upploppet?

MEP försöker sig på framsteg med EU-patent, ifrågasätter medlemsländernas integritet samt ger sin synpunkt på nödlån till Spaniens banker, samtidigt som bönderna kräver bättre mjölkpriser.

EU-patent / CIA-flyg / Spanien / Mjölk

MEP blickar lugnt emot framtiden för Europas gemenskapspatent. Detta efter stormen över rådets ensidiga förslag om förändringar i texten.

Patentproblematik

Patent kostar 2000 euro i USA och upp till 40 000 euro i Europa. Det gemensamma EU-patentet ska bli enklare och billigare, men det är komplicerat att genomföra.

Reportaget: Ett gemensamt patent

Det kan snart bli billigare att skydda innovationer i EU, men detaljerna är inte klara. Fler nyheter.

Nyheterna: EU-patent

Det kan snart bli billigare att skydda innovationer i EU, men detaljerna �r inte klara.

EU-patent

Effektivare användning av resurser, ett gemensamt patent och utfrågning av en kommissionär står på ledamöternas agenda i Bryssel nästa vecka.

Visar 5 resultat för direktströmning för ""